Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Asp-ser-asp-pro-arg
2. Aspartyl-seryl-aspartyl-prolyl-arginine
3. Hepp
4. Human Ige Pentapeptide
5. Ige Pentapeptide
6. Pentapeptidedsdrr
7. Pentigide
8. Pentigide, (l-asp-d-ser-l-asp-l-pro-l-arg)-isomer
9. Pentyde
1. Pentyde
2. Hamburger Pentapeptide
3. 62087-72-3
4. Hepp
5. Human Ige Pentapeptide
6. Pentigetida
7. Pentigetidum
8. Pentigetid
9. Ige Pentapeptide
10. Pentigide
11. Asp-ser-asp-pro-arg
12. Pentyde (tn)
13. Pentapeptide Dsdpr
14. Pentigetide (usan/inn)
15. Yg3j18t1ux
16. (2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic Acid
17. Hep-p
18. Pentigetide [usan:inn]
19. Pentigetidum [inn-latin]
20. Unii-yg3j18t1ux
21. Pentigetida [inn-spanish]
22. Pentapeptide-dsdpr
23. Pentigetide [mi]
24. Pentigetide [inn]
25. Pentigetide [usan]
26. Schembl29861
27. Aspartylserylaspartylprolylarginine
28. Dtxsid30977675
29. Chebi:135842
30. Hy-p3746
31. Zinc56897657
32. N(sup 2)-(1-(n-(n-l-alpha-aspartyl-l-seryl)-l-alpha-aspartyl)-l-prolyl)-l-arginine
33. Cs-0620399
34. D05423
35. L-aspartyl-l-seryl-l-aspartyl-l-prolyl-l-arginine
36. Q27294502
37. L-.alpha.-aspartyl-l-seryl-l-.alpha.-aspartyl-l-prolyl-l-arginine
38. L-arginine, N(sup 2)-(1-(n-(n-l-alpha-aspartyl-l-seryl)-l-alpha-aspartyl)-l-prolyl)-
39. (2s)-2-{[(2s)-1-[(2s)-2-[(2s)-2-[(2s)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic Acid
40. (s)-2-((s)-1-((s)-2-((s)-2-((s)-2-amino-3-carboxypropanamido)-3-hydroxypropanamido)-3-carboxypropanoyl)pyrrolidine-2-carboxamido)-5-guanidinopentanoic Acid
41. L-arginine, N(sup 2)-(1-(n-(n-l-.alpha.-aspartyl-l-seryl)-l-.alpha.-aspartyl)-l-prolyl)-
42. N(sup 2)-(1-(n-(n-l-.alpha.-aspartyl-l-seryl)-l-.alpha.-aspartyl)-l-prolyl)-l-arginine
43. N~2~-[{1-[2-({2-[(2-amino-3-carboxy-1-hydroxypropylidene)amino]-1,3-dihydroxypropylidene}amino)-3-carboxypropanoyl]pyrrolidin-2-yl}(hydroxy)methylidene]arginine
Molecular Weight | 588.6 g/mol |
---|---|
Molecular Formula | C22H36N8O11 |
XLogP3 | -9.2 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 17 |
Exact Mass | 588.25035399 g/mol |
Monoisotopic Mass | 588.25035399 g/mol |
Topological Polar Surface Area | 330 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 1030 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?